S Cogoi
Overview
Explore the profile of S Cogoi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cogoi S, Jakobsen U, Pedersen E, Vogel S, Xodo L
Sci Rep
. 2016 Dec;
6:38468.
PMID: 27929127
KRAS is mutated in >90% of pancreatic ductal adenocarcinomas. As its inactivation leads to tumour regression, mutant KRAS is considered an attractive target for anticancer drugs. In this study we...
2.
Cogoi S, Codognotto A, Rapozzi V, Meeuwenoord N, van der Marel G, Xodo L
Biochemistry
. 2005 Aug;
44(31):10510-9.
PMID: 16060660
Mutations in the Kirsten ras (KRAS) gene are present in almost all pancreatic adenocarcinomas, and one common mutation is at codon 12: GGT (Gly) is transformed into GAT (Asp). In...
3.
Xodo L, Cogoi S, Rapozzi V
Curr Pharm Des
. 2004 Mar;
10(7):805-19.
PMID: 15032705
A current goal in molecular medicine is the development of new strategies for the selective inhibition of cancer-critical genes. Triplex-forming oligonucleotides and peptide nucleic acids bind to the double helix...
4.
Cogoi S, Rapozzi V, Quadrifoglio F, Xodo L
Biochemistry
. 2001 Feb;
40(5):1135-43.
PMID: 11170438
The murine Ki-ras promoter contains a unique polypurine--polypyrimidine [poly(R.Y)] sequence between -290 and -320 from the 3' boundary of exon phi. Previously we demonstrated triplex formation and transcription inhibition promoted...
5.
Cogoi S, Suraci C, Del Terra E, Diviacco S, van der Marel G, van Boom J, et al.
Antisense Nucleic Acid Drug Dev
. 2000 Sep;
10(4):283-95.
PMID: 10984122
Exogenous triplex-forming oligodeoxynucleotides (TFO) have the capacity to modulate in vivo the expression of individual genes. As the administration of TFO to cells is not without problems, we analyzed the...
6.
Carrella M, Feldman D, Cogoi S, Csillaghy A, WEINHOLD P
Hepatology
. 1999 May;
29(6):1825-32.
PMID: 10347126
An increase of biliary lipid secretion is known to occur in the rat under sustained administration of statin-type 3-hydroxy-3-methylglutaryl (HMG) coenzyme A (CoA) reductase inhibitors. The present study has addressed...
7.
Calligaris R, Bottardi S, Cogoi S, Apezteguia I, Santoro C
Proc Natl Acad Sci U S A
. 1995 Dec;
92(25):11598-602.
PMID: 8524811
GATA-1 is a zinc-finger transcription factor that plays a critical role in the normal development of hematopoietic cell lineages. In human and murine erythroid cells a previously undescribed 40-kDa protein...